- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£210.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£135.78
7D
0.2%
1Y
23.1%
Gilead Sciences
Market Cap: US$150.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.87
7D
-2.6%
1Y
12.3%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,450.00
7D
-1.4%
1Y
-0.09%
Orion Oyj
Market Cap: €9.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€68.80
7D
-0.5%
1Y
7.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥36.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥83.05
7D
-1.5%
1Y
-12.9%
Xiamen Amoytop Biotech
Market Cap: CN¥23.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.33
7D
7.9%
1Y
-18.1%